ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Senate Subcommittee Okays $1 billion For NCI In FY 1980, Agrees To Block Obey Reprogramming

June 15, 1979

ASCO, NCCS Call For Oncology Center

September 13, 2002

Governors Hear Pitch For State Cancer Control Increased Effort

August 3, 1979

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

President’s Budget Would Permit NCI Funding Of Only 23.2% Of Approved Traditional Grants

January 26, 1979

Amid Protests Over Grant Paylines, NCI’s Niederhuber Tells Scientists To Get “Leaner And Better”.

April 7, 2006